Bisacodyl是一种刺激性泻药,直接作用于结肠产生排便效应。
Bisacodyl (INN) is a stimulant laxative drug that works directly on the colon to produce a bowel movement.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Ikarashi N, et al. Am J Physiol Gastrointest Liver Physiol, 2011, 301(5), G887-895.
分子式 C22H19NO4 |
分子量 361.39 |
CAS号 603-50-9 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 70 mg/mL |
Water Insoluble |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01011426 | Postoperative Nausea and Vomiting|Abdominal Pain | Drug: Bisacodyl|Drug: placebo | The Cooper Health System | Phase 2 | 2009-04-01 | 2014-01-16 |
NCT02980562 | Bowel Disease|Colon Adenoma | Drug: Polyethylene Glycols|Drug: Bisacodyl | Korea University Anam Hospital | Phase 3 | 2015-05-01 | 2016-12-01 |
NCT01452737 | Colonoscopy | Drug: Standard Bowel Prep|Drug: 2L Golytely/bisacodyl | University of British Columbia | 2011-11-01 | 2013-09-17 | |
NCT01509131 | Colonoscopy | Drug: 2L PEG-CS plus bisacodyl|Drug: 2L PEG-ASC | Promefarm S.r.l. | Phase 4 | 2010-03-01 | 2012-01-11 |
NCT00526097 | Constipation | Drug: Bisacodyl 10 mg|Drug: Placebo | Boehringer Ingelheim | Phase 3 | 2007-09-01 | 2013-12-13 |
NCT01745835 | Healthy Person|Bowel Preparation Before Colonoscopy | Drug: 2L Coolprep|Drug: 1L Coolprep and Bisacodyl | Seoul National University Hospital | Phase 3 | 2013-01-01 | 2013-05-03 |
NCT02123017 | Colonoscopy Preparation | Drug: 90 grams of Crystalline Lactulose|Drug: 135 grams of Crystalline Lactulose|Drug: 180 grams of Crystalline Lactulose | Cumberland Pharmaceuticals | Phase 2 | 2014-04-01 | 2016-01-27 |
NCT01415687 | Bowel Preparation for Colonoscopy | Drug: Polyethylene Glycol-Based Lavage|Drug: Pico-Salax (Magnesium Citrate) plus Bisacodyl | University of Calgary | Phase 3 | 2011-05-01 | 2012-05-30 |
NCT00509327 | Postoperative Ileus | Drug: bisacodyl|Drug: glucosemonohydricum | University Hospital, Basel, Switzerland | Phase 4 | 2004-11-01 | 2007-07-30 |
NCT01887158 | Intestinal Cancer | Drug: Polyethylene glycol|Drug: Bisacodyl | Ospedale Santa Maria delle Croci | Phase 4 | 2013-07-01 | 2014-06-15 |
NCT02211911 | Healthy | Drug: Bisacodyl|Drug: Sodium picosulfate | Boehringer Ingelheim | Phase 1 | 2008-02-01 | 2014-08-07 |
NCT02211976 | Constipation | Drug: Bisacodyl|Drug: Simeticone | Boehringer Ingelheim | Phase 3 | 2003-10-01 | 2014-08-07 |
NCT01063049 | Preparation for Colonoscopy | Drug: Gatorade/Miralax|Drug: NuLytely|Drug: Bisacodyl|Drug: Placebo | Gastroenterology Services, Ltd. | Phase 4 | 2010-02-01 | 2013-11-15 |
NCT01427296 | Colon Cleansing | Drug: Polyethylene glycol|Drug: Oral sodium phosphate solution | Valeant Pharmaceuticals International, Inc. | Phase 4 | 2011-08-01 | 2014-05-30 |
NCT02386449 | Bowel Preparation | Drug: sodium picosulfate, magnesium oxide and citric acid (Picoprep)|Drug: mannitol|Drug: Bisacodyl | Ferring Pharmaceuticals | Phase 4 | 2015-02-01 | 2016-01-11 |
NCT02609607 | Constipation|Fecal Incontinence|Multiple Sclerosis | Drug: Bisacodyl|Other: Placebo | University of Pittsburgh|Consortium of Multiple Sclerosis Centers | Phase 2 | 2016-06-01 | 2016-10-25 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们